Exact Therapeutics AS

EXACT Therapeutics AS, a clinical stage biotech company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology, infectious diseases, and neurological conditions. The company's ACT platform is under Phase I multi-center international clinical trial in patients with liver metastases secondary to colorectal/pancreatic cancer. EXACT Therapeutics AS has a collaboration with GE Healthcare to develop an ultrasound probe to be used in studies using acoustic cluster therapy across various disease conditions. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was incorporated in 2012 and is based in Oslo, Norway. Show More...